Proton Therapy at PSI
Number of patients
Since 1984 more than 7400 patients with ocular melanomas have been treated at PSI. This places PSI among the centers with the largest experience with treatment of this rare disease worldwide. Since 1996 more than 1700 patients from all over Europe have been treated at our Gantrys, of which more than 600 were children or adolescents at the time. These patients were suffering from brain, skull-base or spinal cord tumors, or sarcomas.
The continuous advancement in proton therapy has been funded by PSI itself, by sponsors and benefactors, as well as by technology transfer licenses from industry. PSI specialists put their long years of technical and clinical experience into further practice by advising clinics during their specification and purchasing phases and during the installation and operation of proton therapy facilities. As a leader in R&D of proton therapy technology, PSI also provides advanced training and education in all areas of proton therapy. Meanwhile, the PSI team has gained over 30 years of experience in tumor treatment with proton therapy.